Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
- Status
- TERMINATED
- Phase
- NA
Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis
- Status
- COMPLETED
- Phase
- N/A
STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
- Status
- TERMINATED
- Phase
- PHASE3
cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project
- Status
- COMPLETED
- Phase
- NA
Evaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In Melanoma
- Status
- COMPLETED
- Phase
- N/A
Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers
- Status
- COMPLETED
- Phase
- N/A
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
- Status
- COMPLETED
- Phase
- NA
Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
- Status
- COMPLETED
- Phase
- PHASE3
Trial of pIL-12 Electroporation Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Minimally Invasive Groin Dissection for Melanoma
- Status
- COMPLETED
- Phase
- NA
Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation
- Status
- TERMINATED
- Phase
- PHASE2
Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma
- Status
- COMPLETED
- Phase
- PHASE1